Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world. Generex Biotechnology Corporation (OTCMKTS:GNBT) stock opened at $0.04 in last session, and closed at $0.0390, while the day range of Generex Biotechnology Corporation (OTCMKTS:GNBT) stock is $0.04 – $0.04.
Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) issued an update on its FY14 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $8.25-8.75 for the period, compared to the Thomson Reuters consensus estimate of $8.63, Analyst RN reports. The company issued revenue guidance of $8.2-8.6 billion, compared to the consensus revenue estimate of $8.39 billion. Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) stock opened at $151.26 in last session, and closed at $148.00 by gaining 1.13%. The 52 week range of $65.17 – $153.10. Company’s market capitalization is $49.38B.
Delcath Systems, Inc. (NASDAQ:DCTH) announced that it will host a conference call and webcast on Wednesday, March 12, 2014 at 4:30 p.m. Delcath Systems, Inc. (NASDAQ:DCTH) stock decreased -2.29% and finished the last session at $0.303. The EPS of the stock remained -0.40. Company’s market capitalization is $30.02M.
Acura Pharmaceuticals (NASDAQ:ACUR) major shareholder Claudius Llc sold 44,019 shares of the stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1.97, for a total value of $86,717.43. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) stock opened the session at $1.96, and closed the session at $2.03. The 52 week range of the Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) stock remained $1.35 – 3.78 and the day range was $1.92 – 2.12.